Rigel Pharmaceuticals, Inc. (RIGL)
40.84
-3.66
(-8.22%)
USD |
NASDAQ |
Jan 09, 16:00
40.90
+0.06
(+0.15%)
After-Hours: 20:00
Rigel Pharmaceuticals Research and Development Expense (Annual): 23.38M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 119.64M |
| Ironwood Pharmaceuticals, Inc. | 109.41M |
| Catalyst Pharmaceuticals, Inc. | 12.65M |
| Perspective Therapeutics, Inc. | 39.33M |
| Vertex Pharmaceuticals, Inc. | 3.630B |